Proair Respiclick
FDA Label NDC 53002-1750

41 label sections · Submitted to the FDA by Rpk Pharmaceuticals, Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Rpk Pharmaceuticals, Inc. for the product Proair Respiclick (NDC 53002-1750). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1.1 bronchospasm, 1.2 exercise-induced bronchospasm, 2.1 recommended dosage for bronchospasm, 2.2 recommended dosage for exercise-induced bronchospasm, 2.3 administration and maintenance information, 2.4 dose counter, 3 dosage forms and strengths, 4 contraindications, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.